Live Breaking News & Updates on Catherine Leveau

Stay updated with breaking news from Catherine leveau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Oto

MONTPELLIER, France (BUSINESS WIRE) Regulatory News:Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the European Medicine. ....

France General , Institut Pasteur , Catherine Leveau , Matthew Cole Jessica Hodgson , Committee For Orphan Medicinal Products , Regulatory Affairs , European Medicines Agency , European Commission , Health Technology Assessments Htas , International Media Relations , Consilium Strategic Communications , Regulatory News , Orphan Medicinal Products , Orphan Drug Designation , Quality Assurance Director , Clinical Trial Application , Health Technology Assessments , Cisplatin Induced Ototoxicity , Cochlear Limited , Investor Relations ,

Sensorion to participate in the Inner Ear Biology Workshop in September 2022

Regulatory News: Sensorion (FR0012596468 ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent ....

France General , Christophe Tran Van Ba , Institut Pasteur , Mary Jane Elliott Jessica Hodgson , Catherine Leveau , Strategic Communications , International Media Relations , Regulatory News , Inner Ear Biology Workshop , Preclinical Scientist , Sudden Sensorineural Hearing Loss , Poster Sessions , Cisplatin Induced Ototoxicity , Cochlear Limited , Investor Relations Communication , Jessica Hodgson ,

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the ....

United States , France General , Institut Pasteur , Mary Jane Elliott Jessica Hodgson , Catherine Leveau , Otmane Boussif , Sensorion Preclinical Development , Panel Discussion , International Media Relations , Consilium Strategic Communications , Regulatory News , Preclinical Development Director , Gene Therapy , Gene Therapy Neurological Disorders Europe , Laurent Desire , Chief Technical Officer , Post Marketing Activities , Cell Gene Therapy , Cell Gene Therapy Summit , Advancing Gene Therapy , Hearing Disorders , Control Strategy , Christine Le Bec , Cisplatin Induced Ototoxicity , Cochlear Limited , Investor Relations Communication ,

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium an

MONTPELLIER, France (BUSINESS WIRE) Regulatory News:Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of member. ....

United States , France General , Institut Pasteur , Mary Jane Elliott Jessica Hodgson , Catherine Leveau , Otmane Boussif , Sensorion Preclinical Development , Panel Discussion , International Media Relations , Consilium Strategic Communications , Regulatory News , Preclinical Development Director , Gene Therapy , Gene Therapy Neurological Disorders Europe , Laurent Desire , Gene Therapy Neurological Disorders , Chief Technical Officer , Post Marketing Activities , Gene Therapy Summit , Advancing Gene Therapy , Hearing Disorders , Control Strategy , Christine Le Bec , Cisplatin Induced Ototoxicity , Cochlear Limited , Investor Relations ,

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation

Australian approval follows recent trial approval by regulatory authorities in France Regulatory News: Sensorion (FR0012596468 ALSEN), a pioneering clinical-stage biotechnology company which ....

Institut Pasteur , Mary Jane Elliott Jessica Hodgson , Catherine Leveau , Strategic Communications , Cochlear Ltd , Drug Administration , International Media Relations , Chief Medical Officer , Orphan Drug Designation , Investigational New Drug , Cisplatin Induced Ototoxicity , Cochlear Limited , Investor Relations Communication , Jessica Hodgson ,